Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
No clinical trials have been registered for primary peritoneal serous/papillary carcinoma.
4 publications have been identified in PubMed for primary peritoneal serous/papillary carcinoma. Kisho has analyzed 3 by research type. Research spans Case Report / Case Series (67%) and Epidemiology / Natural History (33%).
Gatta G (2025). [PMID: 40180806](https://pubmed.ncbi.nlm.nih.gov/40180806/). *European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology*. [Epidemiology / Natural History]
Masoud R (2025). [PMID: 40578237](https://pubmed.ncbi.nlm.nih.gov/40578237/). *International journal of surgery case reports*. [Case Report / Case Series]
Taninaka N (2025). [PMID: 39289950](https://pubmed.ncbi.nlm.nih.gov/39289950/). *International journal of surgical pathology*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:07 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning primary peritoneal serous/papillary carcinoma
Updated May 29, 2026
A rare case report details primary peritoneal hydatidosis presenting as an abdominal mass, contributing to the understanding of this uncommon condition. This case highlights the need for awareness and further research into hydatid disease.
A new study discusses a multidisciplinary management approach for paraneoplastic pemphigus associated with primary peritoneal clear cell carcinoma. This research highlights the complexities of treating this rare condition and emphasizes the need for collaborative care.